• LAST PRICE
    29.8000
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    29.5800/ 5
  • Ask / Lots
    29.6900/ 9
  • Open / Previous Close
    0.0000 / 29.8000
  • Day Range
    ---
  • 52 Week Range
    Low 29.7900
    High 45.2100
  • Volume
    3,900
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Friday's close: 30.25
TimeVolumeGLPG
09:32 ET132730.38
09:34 ET20030.4
09:38 ET112030.23
09:39 ET19730.27
09:43 ET22230.29
09:45 ET658530.22
09:48 ET216930.17
09:50 ET10030.205
09:56 ET21730.18
09:59 ET10030.21
10:01 ET78030.18
10:03 ET59930.17
10:06 ET10030.15
10:08 ET10630.16
10:10 ET260030.1
10:12 ET20030.1
10:15 ET20030.06
10:17 ET130030.1
10:19 ET10030.07
10:24 ET63830.05
10:26 ET10030.05
10:28 ET40030.04
10:30 ET30030.04
10:32 ET30030.04
10:33 ET10030.05
10:35 ET10030.05
10:37 ET10030.065
10:39 ET10030.04
10:42 ET10030.055
10:46 ET509030.02
10:48 ET1070030
10:50 ET20029.96
10:51 ET50029.96
10:53 ET29729.94
10:55 ET100029.94
10:57 ET358029.97
11:00 ET40029.93
11:02 ET10029.93
11:04 ET10029.93
11:06 ET20029.94
11:08 ET20029.945
11:13 ET10029.91
11:15 ET70029.905
11:18 ET30029.92
11:24 ET90029.895
11:26 ET20029.9
11:27 ET60029.91
11:31 ET20029.96
11:38 ET40029.93
11:42 ET10029.92
11:49 ET10029.92
11:51 ET20029.95
11:54 ET10029.95
11:58 ET10029.92
12:03 ET10029.92
12:05 ET10029.92
12:07 ET60029.895
12:09 ET30029.915
12:12 ET50729.89
12:14 ET10029.9
12:16 ET10029.915
12:21 ET10029.9
12:23 ET311729.91
12:27 ET10029.89
12:32 ET20029.88
12:38 ET40029.88
12:39 ET10029.87
12:41 ET10029.89
12:45 ET70029.86
12:48 ET156729.86
12:56 ET20029.84
12:57 ET30029.86
12:59 ET10029.88
01:01 ET30029.84
01:03 ET20029.82
01:06 ET15429.8561
01:08 ET10029.84
01:10 ET10029.84
01:14 ET10029.82
01:19 ET136029.825
01:21 ET10029.82
01:24 ET70029.845
01:28 ET50029.82
01:30 ET100029.82
01:32 ET60029.82
01:33 ET100029.82
01:35 ET150029.84
01:39 ET20029.83
01:44 ET10029.835
01:46 ET30029.855
01:48 ET59829.885
01:57 ET10029.87
02:02 ET77029.92
02:06 ET20029.88
02:11 ET14429.88
02:13 ET20029.89
02:18 ET20029.89
02:20 ET20029.885
02:22 ET17829.86
02:24 ET10029.88
02:29 ET40029.89
02:31 ET10029.925
02:33 ET10029.91
02:42 ET30029.91
02:44 ET25829.9
02:45 ET20029.8973
02:49 ET50729.87
02:51 ET39029.86
02:56 ET40029.83
02:58 ET10029.83
03:00 ET30029.85
03:02 ET10029.85
03:03 ET50029.82
03:05 ET10029.829
03:07 ET30029.82
03:09 ET10029.81
03:16 ET40029.8
03:18 ET70029.79
03:20 ET70029.795
03:21 ET130029.81
03:23 ET30029.82
03:27 ET30029.855
03:32 ET10029.865
03:34 ET20029.84
03:36 ET45829.84
03:38 ET40029.84
03:39 ET49829.83
03:41 ET39029.83
03:43 ET143629.805
03:45 ET250029.855
03:48 ET20029.865
03:50 ET70029.87
03:52 ET77829.86
03:54 ET162829.82
03:56 ET53829.83
03:57 ET121629.835
03:59 ET1644029.8
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesGLPG
Galapagos NV
2.0B
-463.5x
---
United StatesMRVI
Maravai LifeSciences Holdings Inc
2.0B
-9.0x
---
United StatesBEAM
Beam Therapeutics Inc
2.1B
-13.7x
---
United StatesDNLI
Denali Therapeutics Inc
2.5B
-16.4x
---
United StatesDNA
Ginkgo Bioworks Holdings Inc
1.9B
-2.1x
---
United StatesTGTX
TG Therapeutics Inc
2.2B
996.5x
---
As of 2024-04-16

Company Information

Galapagos NV is a Belgium-based clinical-stage biotechnology company. The Company is engaged in the discovery and development of small molecule medicines with modes of action. Its pipeline comprises Phase 3, 2, 1, pre-clinical studies and discovery small-molecule and antibody programs in cystic fibrosis, inflammation, and other indications. The Company focuses on developing a portfolio of clinical-stage therapies for the enhancement of existing treatment paradigms. It develops transformational medicines in areas of high unmet need by combining internal with external science with the goal to add years of life and improve of life of patients across the globe. It discovers which proteins that are involved in causing diseases such as, rheumatoid, arthritis, inflammatory bowel disease and fibrosis. The Company acquired CellPoint and AboundBio in order to develop a cell therapy, which is a potential transformative treatment of different types of cancer.

Contact Information

Headquarters
Generaal De Wittelaan L11 A3MALINES (MECHELEN), Belgium 2800
Phone
---
Fax
---

Executives

Chairman of the Board, Chief Executive Officer
Paulus Stoffels
Chief Financial Officer, Chief Operating Officer
Thad Huston
Chief Human Resource Officer
Annelies Missotten
General Counsel
Valeria Cnossen
Member of the Management Board, Chief Commercial Officer
Michele Manto

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$2.0B
Revenue (TTM)
$304.8M
Shares Outstanding
65.9M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.26
EPS
$-0.06
Book Value
$45.06
P/E Ratio
-463.5x
Price/Sales (TTM)
6.5
Price/Cash Flow (TTM)
---
Operating Margin
-30.75%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.